DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 129 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q3 2023. The put-call ratio across all filers is 2.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $952,287 | -12.3% | 77,611 | -14.7% | 0.00% | – |
| Q2 2023 | $1,086,074 | +41.1% | 90,961 | +58.0% | 0.00% | – |
| Q1 2023 | $769,551 | +72.6% | 57,558 | +177.8% | 0.00% | – |
| Q4 2022 | $445,916 | +6.2% | 20,721 | -1.2% | 0.00% | – |
| Q3 2022 | $420,000 | +16.0% | 20,979 | +3.8% | 0.00% | – |
| Q2 2022 | $362,000 | +265.7% | 20,212 | +102.1% | 0.00% | – |
| Q1 2022 | $99,000 | -45.0% | 10,000 | -6.1% | 0.00% | – |
| Q4 2021 | $180,000 | -24.4% | 10,652 | +6.0% | 0.00% | – |
| Q3 2021 | $238,000 | – | 10,053 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 6,964,301 | $139,495,000 | 56.26% |
| PATHWAY CAPITAL MANAGEMENT, LP | 403,127 | $8,075,000 | 25.88% |
| Atlas Venture Life Science Advisors, LLC | 8,169,171 | $163,628,000 | 18.06% |
| RA Capital Management | 7,040,622 | $141,024,000 | 3.01% |
| COMMODORE CAPITAL LP | 739,661 | $14,815,000 | 2.38% |
| Nicholas Investment Partners, LP | 757,407 | $15,171,000 | 1.41% |
| Boxer Capital, LLC | 1,189,943 | $23,835,000 | 1.34% |
| Parkman Healthcare Partners LLC | 212,191 | $4,250,000 | 1.21% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $8,012,000 | 0.98% |
| Samsara BioCapital, LLC | 196,425 | $3,934,000 | 0.92% |